European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

Evolve Your Success

OCTOBER 31, 2023

It’s hard to divvy all that because we work with medical affairs and medical science liaisons. By 2027, they are projected to be about $10 billion. Honestly, because it’s temporary, when we get ready to take out the temporary leads, some of the patients are like, “I don’t want that removed.”

Engineering 52

Engineering Sales Medical sales Medical 52

PM360

DECEMBER 12, 2024

billion by 2027, growing at a CAGR of 25.8%. Hait: When leading R&D at Johnson & Johnson , the World Without Disease Accelerator revolutionized healthcare by focusing on disease prevention rather than merely treating diseases. Hait’s insights on advancing innovation and collaboration in the fight against cancer.

Healthcare 52

Healthcare Healthcare Leads Medical 52